Management

Paul K. Nichols, Jr.

President and Chief Executive Officer

Paul has 32 years experience with rapidly growing companies in the medical device industry, with the past 24 as an executive and entrepreneur in the musculoskeletal sector. Between 1995 and 2005 he was a founder and CEO of three orthopedic surgery technology companies with successful exits, the most recent being Nexa Orthopedics which was acquired by Tornier (NASD:TRNX) in 2007. Mr. Nichols currently serves as a director of several early stage medical technology companies and also provides management consulting services to growth stage businesses.

Janet Krevolin, Ph.D.

Chief Technical Officer

Janet has over 20 years experience in research and product development in the orthopedic surgery industry. Prior to joining Bio2 she held the position of Vice President, Global Product Development for Zimmer Holdings, Inc. (NYSE:ZMH). Prior responsibilities included management of Zimmer's European research activities. Janet has a doctorate in Mechanical Engineering from the University of Texas and a bachelors degree from Wellesley College.

Art O'Dea

VP Legal and Regulatory Affairs

Art is responsible for managing Bio2's legal and regulatory affairs. Art served as VP of Intellectual Property for GEO2 Technologies, where he built the patent portfolio relating to the CLM technology. Prior to GEO2, Art was Patent Counsel for Cognex Corporation where he managed IP matters, including patent prosecution, patent litigation, and IP licensing. Art has a BSME from the University of Vermont, an MS-CIM from BYU, and a JD from the Massachusetts School of Law. He is a member of the Massachusetts Bar and a registered Patent Attorney with the United States Patent and Trademark Office.